Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
LFVN
HoldBargain BinLifeVantage Corporation · Consumer Defensive · United States · $80M · Avg Vol: $350K/d
COMPANY DESCRIPTION
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2027E | 2028E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 206.4M | 213.4M | 200.2M | 228.5M | 3.5% | 182.6M | 207.1M | 209.9M | -2.8% |
| EPS | 0.24 | 0.20 | 0.24 | 0.79 | 48.7% | 0.40 | 0.46 | 0.54 | -11.6% |
| Shares | 12.5M | 12.6M | 12.5M | 12.4M | -0.5% | 12.5M | — | — | — |
| Debt | 15.8M | 13.1M | 13.6M | 11.7M | -9.5% | 9.9M | — | — | — |
| Equity | 31.5M | 34.6M | 26.0M | 34.6M | 3.2% | — | — | — | — |
| Op CF | 8.0M | 6.8M | 12.2M | 11.9M | 14.3% | 10.2M | — | — | — |
| Inv CF | -1.5M | -3.1M | -2.2M | -1.4M | — | — | — | — | — |
| Fin CF | -9.0M | -2.4M | -14.4M | -7.6M | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Consumer Defensive, ranked by industry match, size, and score similarity. Cross-listings of LFVN are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| LFVN | LifeVantage Corporation(you) | $80M | 47 | Hold |
| HAIN | The Hain Celestial Group, Inc. | $66M | 33 | Sell |
| FTLF | FitLife Brands, Inc. | $92M | 29 | Sell |
| USNA | USANA Health Sciences, Inc. | $259M | 43 | Hold |
| NATR | Nature's Sunshine Products, Inc. | $250M | 56 | Hold |
| BRCC | BRC Inc. | $120M | 20 | Sell |
| BRID | Bridgford Foods Corporation | $56M | 14 | Strong Sell |
| DDC | DDC Enterprise Limited | $63M | 10 | Strong Sell |
| LWAY | Lifeway Foods, Inc. | $398M | 36 | Hold |
| NPRA.CN | Nepra Foods Inc. | $43M | 14 | Strong Sell |
Peer medians: ROE 9.2% · P/E 20.6x · Gross margin 34.5%